ID: h-76d375b520
Hypothesis
Gamma entrainment enhances TREM2-mediated microglial clearance of Aβ plaques via reduced CDK5 signaling
40 Hz neural activity induces Ca2+ oscillations in microglia through P2X7 receptor activation, promoting TREM2 phosphorylation and its association with SYK kinase.
🧬 TREM2 (triggering receptor expressed on myeloid cells 2); SYK (spleen tyrosine kinase); CDK5🩺 alzheimers🎯 Composite 68%💱 $0.62▼4.8%proposed
Alzheimer's disease
EvidencePending (0%)📖 0 cit🗣 1 debates✓ 3 support✗ 3 oppose
✓ All Quality Gates Passed
🧪 Overview
40 Hz neural activity induces Ca2+ oscillations in microglia through P2X7 receptor activation, promoting TREM2 phosphorylation and its association with SYK kinase. This enhances microglial clustering around plaques and phagocytic clearance of amyloid-β oligomers and fibrils. The most mechanistically fragmented hypothesis: P2X7 to TREM2 phosphorylation is unspecified, the activating phosphorylation site and kinase are undefined, and the temporal paradox (TREM2 operates on days-weeks; plaque reduction occurs within hours) is unresolved.
🧬 Mechanism
🔗 Mechanism from KG for TREM2 (triggering receptor expressed on myeloid cells 2); SYK (spleen tyrosine kinase); CDK5
Auto-built from this analysis's top knowledge-graph edges.
graph TD
excitation_inhibition_imb["excitation/inhibition imbalance"] -->|associated with| Early_Alzheimer_S_Disease["Early Alzheimer'S Disease"]
PV__interneuron_activatio["PV+ interneuron activation"] -->|associated with| excitation_inhibition_bal["excitation/inhibition balance"]
BDNF["BDNF"] -->|activates| TrkB_receptors["TrkB receptors"]
PV__interneuron_activatio_1["PV+ interneuron activation"] -->|causes| Memory_Improvements["Memory Improvements"]
BDNF_2["BDNF"] -->|regulates| gamma_entrainment_memory_["gamma entrainment memory benefits"]
sess_SRB_2026_04_28_h_bdb["sess_SRB-2026-04-28-h-bdbd2120_task_9aae8fc5"] -->|causal extracted| processed["processed"]
style excitation_inhibition_imb fill:#4fc3f7,stroke:#333,color:#000
style Early_Alzheimer_S_Disease fill:#ef5350,stroke:#333,color:#000
style PV__interneuron_activatio fill:#4fc3f7,stroke:#333,color:#000
style excitation_inhibition_bal fill:#81c784,stroke:#333,color:#000
style BDNF fill:#ce93d8,stroke:#333,color:#000
style TrkB_receptors fill:#4fc3f7,stroke:#333,color:#000
style PV__interneuron_activatio_1 fill:#4fc3f7,stroke:#333,color:#000
style Memory_Improvements fill:#4fc3f7,stroke:#333,color:#000
style BDNF_2 fill:#ce93d8,stroke:#333,color:#000
style gamma_entrainment_memory_ fill:#4fc3f7,stroke:#333,color:#000
style sess_SRB_2026_04_28_h_bdb fill:#4fc3f7,stroke:#333,color:#000
style processed fill:#4fc3f7,stroke:#333,color:#000⚖️ Evidence
⚖️ Evidence Matrix3 supports3 contradicts
Contradicts
Temporal paradox: TREM2 operates on days-weeks; plaque reduction occurs within hours
Contradicts
Mechanistic chain is incomplete: undefined intermediates between P2X7 and TREM2 phosphorylation
Contradicts
R47H knock-in is hypomorphic (~50% residual function), not null; results will be ambiguous
📖 Linked Papers
No linked papers recorded for this hypothesis yet.
🏥 Translation
🧬 3D Protein Structure — TREM2
💉 Clinical Trials
No clinical trials data linked to this hypothesis yet.
No curated ClinVar variants loaded for this hypothesis.
Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.
No DepMap CRISPR Chronos data found for TREM2 (triggering receptor expressed on myeloid cells 2); SYK (spleen tyrosine kinase); CDK5.
Run python3 scripts/backfill_hypothesis_depmap.py to populate.
🏆 Tournament
🏆 Arenas / Elo
No arena matches recorded yet. Browse Arenas →
📊 Market Indicators
7d Trend
↘
Falling
7d Momentum
▼ 1.6%
Volatility
Medium
0.0426
Events (7d)
3
Price History
▼4.8%💾 Resource Usage
No resource usage or linked notebooks recorded for this hypothesis yet.
🔮 Predictions
🔎 Predictions vs Observations2 predictions · 0 with recorded observations
| Prediction | Predicted | Observed | Status | Conf |
|---|---|---|---|---|
| IF primary microglia cultures are pre-treated with CDK5 inhibitors (roscovitine 20 µM or flavopiridol) for 30 min prior to 40 Hz mechanical stimulation, THEN TREM2 phosphorylation at Y525/Y533 will in | ≥2-fold increase in p-TREM2 (Y525/Y533) by western blot, ≥1.5-fold increase in co-immunoprecipitated SYK, and ≥40% increase in Aβ42 uptake (ELISA of remaining s | — no observation — | pending | 0.45 |
| IF 5xFAD mice receive daily 1-hour 40 Hz gamma entrainment (optogenetic or auditory) for 7 consecutive days, THEN hippocampal Aβ plaque density will decrease by ≥25% relative to sham-stimulated 5xFAD | Plaque density reduction (estimated from THS + Congo red or [18F]florbetaben PET) of ≥25% in hippocampus of 5xFAD mice after 7 days of gamma stimulation, with a | — no observation — | pending | 0.55 |
🔮 Falsifiable Predictions (2)
pendingconf 55%
IF 5xFAD mice receive daily 1-hour 40 Hz gamma entrainment (optogenetic or auditory) for 7 consecutive days, THEN hippocampal Aβ plaque density will decrease by ≥25% relative to sham-stimulated 5xFAD controls within 2 weeks, AND this effect will be abolished in Trem2 knockout 5xFAD mice.
Predicted outcome: Plaque density reduction (estimated from THS + Congo red or [18F]florbetaben PET) of ≥25% in hippocampus of 5xFAD mice after 7 days of gamma stimulati
Falsification: No significant plaque reduction (<10%) in gamma-stimulated mice versus controls OR equivalent plaque reduction in Trem2 knockout mice receiving gamma stimulation would disprove TREM2 dependence
pendingconf 45%
IF primary microglia cultures are pre-treated with CDK5 inhibitors (roscovitine 20 µM or flavopiridol) for 30 min prior to 40 Hz mechanical stimulation, THEN TREM2 phosphorylation at Y525/Y533 will increase ≥2-fold, SYK recruitment will increase ≥1.5-fold, and Aβ42 phagocytosis will increase ≥40% co
Predicted outcome: ≥2-fold increase in p-TREM2 (Y525/Y533) by western blot, ≥1.5-fold increase in co-immunoprecipitated SYK, and ≥40% increase in Aβ42 uptake (ELISA of r
Falsification: CDK5 inhibition fails to enhance TREM2 phosphorylation or Aβ42 phagocytosis, or 40 Hz stimulation does not alter CDK5 activity (p25/p35 ratio), would disprove CDK5 as negative regulator of TREM2 pathw
▸Metadatasource: v1_phase_c_backfill · origin_type: debate_synthesizer
| source | v1_phase_c_backfill |
| origin_type | debate_synthesizer |
| _schema_version | 1 |
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
0
0 supporting
0 contradicting
0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.